Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioarray is a leading biotechnology company based in Spain, specializing in advanced genetic diagnostics and genomic research services. Founded in 2009, the company utilizes state-of-the-art technologies such as Next-Generation Sequencing (NGS) and microarrays to provide comprehensive solutions in reproductive genetics, oncology, and clinical diagnostics. Their proprietary PGD-Seq platform offers a streamlined workflow for preimplantation genetic testing, while their BioER test assesses endometrial receptivity to improve IVF outcomes. Bioarray serves a global clientele of clinics, hospitals, and research institutions, delivering actionable genetic insights through a robust bioinformatics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioArray.